Compare FEMY & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | AHT |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 29.2M |
| IPO Year | 2021 | 2003 |
| Metric | FEMY | AHT |
|---|---|---|
| Price | $0.65 | $4.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 62.4K |
| Earning Date | 11-14-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,061,502.00 | ★ $1,119,102,000.00 |
| Revenue This Year | $64.02 | N/A |
| Revenue Next Year | $147.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.53 | N/A |
| 52 Week Low | $0.31 | $2.90 |
| 52 Week High | $1.80 | $10.35 |
| Indicator | FEMY | AHT |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 49.67 |
| Support Level | $0.60 | $3.43 |
| Resistance Level | $0.73 | $5.00 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 45.12 | 49.68 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.